tert-butyl 4-[6-({8-cyclopentyl-5-methyl-7-oxo-7H,8H-pyrido[2,3-d]pyrimidin-2-yl}amino)pyridin-3-yl]piperazine-1-carboxylate(CAS: 571189-65-6)

The compound (CAS 571189-65-6) falls under the regulatory framework of REACH in Europe, which requires registration if manufactured or imported in quantities above 1 ton per year. It is also subject to GHS classification for hazardous chemicals, which includes information on physical hazards, health hazards, and environmental hazards. Additionally, FDA guidelines for pharmaceuticals and EPA regulations for environmental protection should be adhered to in the USA.

Alternatives to the compound (CAS 571189-65-6) in synthesis include related pyrimidine derivatives with varying substituents or different scaffolds. Commonly used reagents in synthesis include 5-aminopyrimidines and various amines, which can provide similar functionality but with different structural features.

The research trend for the compound (CAS 571189-65-6) is focused on its potential applications in pharmaceuticals and biotechnology due to its structural features. It is likely to be explored for its therapeutic properties, particularly in oncology. Market trends show increasing interest in developing small molecule inhibitors targeting pyrimidine-based pharmacophores.

Waste containing the compound (CAS 571189-65-6) should be collected in appropriately labeled, sealed containers and stored separately from other waste. The waste should be incinerated or disposed of through a professional hazardous waste disposal service that adheres to local environmental protection regulations. Precautions should be taken to prevent the release of contaminants into the environment.